2024 Boston Pharmaceutical Statistics Symposium - Day 2, Main Event

Tickets on this page are for the Nov 1 research presentations short courses. See for tickets for the short courses on Oct 31.

Join us at the 2024 Boston Pharmaceutical Statistics Symposium on November 1, hosted by the Boston Chapter of the American Statistical Association (BCASA). This annual event, held at Sanofi, Cambridge Crossing - 450 Water St, Cambridge, MA, offers a unique platform for sharing cutting-edge statistical applications and research in the biotech-pharma industry.

It's an ideal opportunity for industry statisticians, academics, students, and professionals interested in pharmaceutical statistical topics to connect and exchange insights within Greater Boston's thriving pharmaceutical community. The symposium features a full day of engaging activities, including thought-provoking invited talks, a dynamic poster session, and ample networking opportunities. Two short courses will be offered on October 31, one day before the symposium.

Don't miss enhancing your knowledge and expanding your professional network. Mark your calendar now and be part of this impactful event!

Our speakers

Keynote speaker:

• Statistical Boom: Opportunities for a Statistician in an era of Quantitative Medicines Development by Margaret Gamalo, Vice President and Statistics Head for Inflammation and Immunology, Global Product Development, Pfizer

Invited speakers:

• Optimal Priors for the Discounting Parameter of the Normalized Power Prior by Joseph Ibrahim, Alumni Distinguished Professor of Biostatistics and the Director of the Biostatistics Core at Lineberger Comprehensive Cancer Center, UNC

• Predicting Probability of Success for Phase III Trials via Propensity-Score-Based External Data Borrowing by Veronica Bunn, Associate Director in Oncology statistics, Takeda

• AI-Generated R Functions Integrated with Proprietary Software for Clinical Trial Simulation by J. Kyle Wathen, Vice President, Scientific Strategy & Product Innovation, Cytel

• Driving Efficiency of Clinical Drug Supply Chains Management in Adaptive Clinical Trials by Zoe Hua, a director biostatistician at Servier Bio-Innovation in late stage clinical development for oncology therapies, Servier

• Using Digital Innovation in Clinical Trials: Function of Advanced Modelling and Data Science by Zhaoling Meng, Associate Vice President, Global Head of Clinical Modeling and Evidence Integration in Evidence Generation and Decision Science, R&D, Sanofi

• Pragmatic Clinical Trials: Future Directions and Design Considerations by Cynthia Hau, Statistician for the Veterans Affairs (VA) Cooperative Studies Program, Boston Coordinating Center

• Practical Steps Toward Model-informed Drug Development using Causal Diagrams by James Rogers, Vice President of Statistics in the Quantitative Sciences Business Unit, Metrum Research Group

• Title TBD by Issa Dahabreh, Associate Professor of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard

More information on the 2024 Boston Pharmaceutical Statistics Symposium can be found on our website.

Please note: Valid photo ID is required at registration and must be presented to the Sanofi security. Requirements to enter Sanofi buildings are subject to change.

Our Sponsors

We thank our colleagues at Sanofi for hosting this event. Financial support from Platinum Sponsor Novo Nordisk, Silver Sponsor BioPier are gratefully acknowledged.

Event Venue & Nearby Stays

Sanofi, 450 Water Street, Cambridge, United States